Thromb Haemost 1966; 16(01/02): 198-206
DOI: 10.1055/s-0038-1655637
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Simple Method for Preparing Fibrinogen[*]

W Straughn III
1   Department of Pathology and Biochemistry, University of North Carolina, Chapel Hill, North Carolina
,
R. H Wagner**
1   Department of Pathology and Biochemistry, University of North Carolina, Chapel Hill, North Carolina
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Summary

A simple new procedure is reported for the isolation of canine, bovine, porcine, and human fibrinogen. Two molar β-alanine is used to precipitate fibrinogen from barium sulfate adsorbed plasma. The procedure is characterized by dependability and high yields. The material is 95% to 98% clottable protein but still contains impurities such as plasminogen and fibrin-stabilizing factor. Plasminogen may be removed by adsorption with charcoal. The fibrinogen preparations exhibit marked stability to freezing, lyophilization, and dialysis. Epsilon-amino-n-caproic acid and gamma-aminobutyric acid which were also studied have the property of precipitating proteins from plasma but lack the specificity for fibrinogen found with β-alanine.

* This investigation was supported by USPHS grants HE-01648 and HE-06350 from the National Institutes of Health.


** This investigator was supported by USPHS research career program award (K3-HE-1147).


 
  • References

  • 1 Denis P. S. Mémoire sur le Sang. Paris 1859
  • 2 Florkin M. Studies in the physical chemistry of the proteins. VII. The solubility of fibrinogen in concentrated salt solutions. J. biol. Chem 87: 629 1930;
  • 3 Smith H. P, Warner E. D, Brinkhous K. M. Prothrombin deficiency and the bleeding tendency in liver injury (chloroform intoxication). J. exp. Med 66: 801 1937;
  • 4 Laki K. Isolierung und Kristallisierung des Fibrinogens aus Schweineblut. Hoppe-Seyler’s Z. physiol. Chem 273: 95 1942;
  • 5 Neurath H, Dees J. E, Fox H. The preparation and properties of human fibrinogen solutions. J. Urol 49: 497 1943;
  • 6 Loewy A. G, Dunathan K, Kriel R, Wolfinger H. L. Fibrinase. I. Purification of substrate and enzyme. J. biol. Chem 236: 2625 1961;
  • 7 Jaques L. B. The reducing properties of fibrinogen. Biochem. J 37: 344 1943;
  • 8 Cohn E. J, Strong L. E, Hughes Jr. W. L, Mulford D. J, Ashworth J. N, Melin M, Taylor H. L. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Amer. chem. Soc 68: 459 1946;
  • 9 Morrison P. R, Edsall J. T, Miller S. G. Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from Fraction I of human plasma. J. Amer. chem. Soc 70: 3103 1948;
  • 10 Kekwick R. A, Mackay M. E. The separation of protein fractions from human plasma with ether. Med. Res. Council, Spec. Rep. Ser. No. 286, 1954
  • 11 Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: with special refence to its preparation and certain properties of the product. Arch. Biochem 13: 231 1947;
  • 12 Blombach B, Blombach M. Purification of human and bovine fibrinogen. Arkiv Kemi 20: 415 1956;
  • 13 Kazal L. A, Amsel S, Miller O. P, Tocantins L. M. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc. Soc. exp. Biol. (N. Y.) 113: 989 1963;
  • 14 Mosesson M. W. The preparation of human fibrinogen free of plasminogen. Biochim. biophys. Acta (Amst.) 57: 204 1962;
  • 15 Wagner R. H, Brinkhous K. M, Penick G. D. Antihemophilic factor: some problems in its study. In: Hemophilia and Other Hemorrhagic States. Brinkhous K. M, and De Nicola P. editors Chapel Hill: The University of North Carolina Press; 1959: 3.
  • 16 Wagner R. H, McLester W. D, Smith M, Brinkhous K. M. Purification of antihemophilic factor (Factor VIII) by amino acid precipitation. Thrombos. Diathes. haemorrh. (Stuttg.) 22: 64 1964;
  • 17 Rasmussen P. S. Purification of thrombin by chromatography. Biochim. biophys. Acta (Amst.) 16: 157 1955;
  • 18 Thelin G. M, Wagner R. H. The action of thrombin on serum albumin. Biochem. Biophys. Res. Commun 2: 219 1959;
  • 19 Laki K. The polymerization of proteins: the action of thrombin on fibrinogen. Arch. Biochem. Biophys 32: 317 1951;
  • 20 Ploug J, Kjeldgaard N. O. Urokinase. An activator of plasminogen from human urine. I. Isolation and properties. Biochim. biophys. Acta (Amst.) 24: 278 1957;
  • 21 Maxwell R. E, Nickel V. S, Lewandowski V. Preparations of plasminogen-deficient fibrinogen and thrombin. Biochem. Biophys. Res. Commun 7: 50 1962;
  • 22 Lorand L, Jacobsen A. Specific inhibitors and the chemistry of fibrin polymerization. Biochemistry 3: 1939 1964;
  • 23 Langdell R. D, Wagner R. H, Brinkhous K. A.I. Effect of antihemophilic factor on one-stage clotting tests. J. Lab. clin. Med 41: 637 1953;
  • 24 Davis B. J. Disc electrophoresis - II. Method and application to human serum proteins. Ann. N. Y. Acad. Sci 121: 404 1964;
  • 25 Richards M. M. The effect of glycine upon the activity coefficient of glycine, egg albumin, and carboxyhemoglobin. J. biol. Chem 122: 727 1937;
  • 26 Edsall J. T, Lever W. F. Effects of ions and neutral molecules on fibrin clotting. J. biol. Chem 191: 735 1951;
  • 27 Grannis G. F, Kazal L. A, Tocantins L. M. The spectrophotometry determination of thrombin activity in plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 13: 330 1965;